| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |